Xinyi Tu

2.1k total citations
38 papers, 972 citations indexed

About

Xinyi Tu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xinyi Tu has authored 38 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Immunology. Recurrent topics in Xinyi Tu's work include DNA Repair Mechanisms (13 papers), Advanced biosensing and bioanalysis techniques (6 papers) and interferon and immune responses (5 papers). Xinyi Tu is often cited by papers focused on DNA Repair Mechanisms (13 papers), Advanced biosensing and bioanalysis techniques (6 papers) and interferon and immune responses (5 papers). Xinyi Tu collaborates with scholars based in United States, China and Czechia. Xinyi Tu's co-authors include Zhenkun Lou, Somaira Nowsheen, Jia Yu, Bo Qin, Liewei Wang, Jian Yuan, Qin Zhou, Fei Zhao, Ping Yin and Robert W. Mutter and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Xinyi Tu

31 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinyi Tu United States	16	627	412	220	126	111	38	972
Wan-Li Liu China	14	507 0.8×	342 0.8×	166 0.8×	172 1.4×	82 0.7×	18	868
Kavitha Balaji United States	9	320 0.5×	381 0.9×	229 1.0×	105 0.8×	142 1.3×	15	829
Erik H. Knelson United States	15	397 0.6×	214 0.5×	183 0.8×	109 0.9×	77 0.7×	22	703
Zhenghu Chen United States	18	754 1.2×	262 0.6×	159 0.7×	161 1.3×	60 0.5×	33	988
Simone Gaedicke Germany	18	362 0.6×	497 1.2×	354 1.6×	137 1.1×	107 1.0×	27	1.0k
Jessica Dal Col Italy	20	469 0.7×	554 1.3×	550 2.5×	125 1.0×	101 0.9×	35	1.2k
Anna Merlo Italy	17	332 0.5×	384 0.9×	254 1.2×	115 0.9×	50 0.5×	32	825
Hyung‐Gyoon Kim United States	17	541 0.9×	405 1.0×	197 0.9×	189 1.5×	134 1.2×	33	1.0k
Adam Studebaker United States	13	396 0.6×	444 1.1×	146 0.7×	140 1.1×	54 0.5×	21	885
Akira Yuno United States	16	459 0.7×	411 1.0×	383 1.7×	66 0.5×	71 0.6×	29	844

Countries citing papers authored by Xinyi Tu

Since Specialization

Citations

This map shows the geographic impact of Xinyi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Tu more than expected).

Fields of papers citing papers by Xinyi Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Tu. The network helps show where Xinyi Tu may publish in the future.

Co-authorship network of co-authors of Xinyi Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyi Tu. A scholar is included among the top collaborators of Xinyi Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyi Tu. Xinyi Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tu, Xinyi, et al.. (2025). Ethical Imperatives for Retrieval-Augmented Generation in Clinical Nursing: Viewpoint on Responsible AI Use. JMIR Medical Informatics. 14. e79922–e79922.

Kloeber, Jake A., Bin Chen, Guangchao Sun, et al.. (2025). KCTD10 is a sensor for co-directional transcription–replication conflicts. Nature. 648(8092). 210–219.

Lunová, Mariia, Xinyi Tu, A. Dejneka, et al.. (2025). Geometrically constrained cytoskeletal reorganisation modulates DNA nanostructures uptake. Journal of Materials Chemistry B. 13(7). 2335–2351. 2 indexed citations

Tu, Xinyi, et al.. (2025). Traditional Chinese medicine in the prevention and treatment of lung cancer metastasis by regulating tumor-associated macrophages: a narrative review. Translational Lung Cancer Research. 14(6). 2281–2295.

Zeng, Xiangyu, Fei Zhao, Xinyi Tu, et al.. (2025). Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a feed-forward loop. Journal of Clinical Investigation. 135(13). 3 indexed citations

Wei, Jun, Yu Ma, Jie Wang, et al.. (2024). Single-cell sequencing reveals that specnuezhenide protects against osteoporosis via activation of METTL3 in LEPR+ BMSCs. European Journal of Pharmacology. 981. 176908–176908. 7 indexed citations

Tu, Xinyi, Leilei Huang, Ting Huang, et al.. (2024). Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids. Journal of Medicinal Chemistry. 67(24). 21916–21933. 4 indexed citations

Lunová, Mariia, Xinyi Tu, A. Dejneka, et al.. (2024). Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells. Chemical Engineering Journal. 498. 155633–155633. 6 indexed citations

Dai, Kun, Yang Xu, Yang Yang, et al.. (2023). Edge Length-Programmed Single-Stranded RNA Origami for Predictive Innate Immune Activation and Therapy. Journal of the American Chemical Society. 145(31). 17112–17124. 7 indexed citations

10.

Dai, Kun, Gong Chen, Yang Xu, et al.. (2023). Single-Stranded RNA Origami-Based Epigenetic Immunomodulation. Nano Letters. 23(15). 7188–7196. 6 indexed citations

11.

Hou, Jing, Huanyao Gao, Qi Hu, et al.. (2023). SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses. Molecular Cell. 83(4). 539–555.e7. 21 indexed citations

12.

Zhou, Qin, Xinyi Tu, Qian Zhu, et al.. (2021). Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining. Cancer Research. 81(12). 3333–3346. 30 indexed citations

13.

Kim, Wootae, Fei Zhao, Huanyao Gao, et al.. (2021). USP13 regulates the replication stress response by deubiquitinating TopBP1. DNA repair. 100. 103063–103063. 17 indexed citations

14.

Zhu, Qian, Jinzhou Huang, Hongyang Huang, et al.. (2021). RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination. Nature Communications. 12(1). 16 indexed citations

15.

Yu, Jia, Bo Qin, Ann M. Moyer, et al.. (2020). Regulation of sister chromatid cohesion by nuclear PD-L1. Cell Research. 30(7). 590–601. 71 indexed citations

16.

Gao, Ming, Guijie Guo, Jinzhou Huang, et al.. (2020). USP52 regulates DNA end resection and chemosensitivity through removing inhibitory ubiquitination from CtIP. Nature Communications. 11(1). 5362–5362. 25 indexed citations

17.

Huang, Jinzhou, Qin Zhou, Ming Gao, et al.. (2020). Tandem Deubiquitination and Acetylation of SPRTN Promotes DNA-Protein Crosslink Repair and Protects against Aging. Molecular Cell. 79(5). 824–835.e5. 42 indexed citations

18.

Zhou, Qin, Jinzhou Huang, Chao Zhang, et al.. (2020). The bromodomain containing protein BRD-9 orchestrates RAD51–RAD54 complex formation and regulates homologous recombination-mediated repair. Nature Communications. 11(1). 2639–2639. 47 indexed citations

19.

Tu, Xinyi, Bo Qin, Yong Zhang, et al.. (2019). PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy. Molecular Cell. 74(6). 1215–1226.e4. 187 indexed citations

20.

Tu, Xinyi, Mohamed M. Kahila, Qin Zhou, et al.. (2018). ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 17(11). 2462–2472. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact